Cytomegalovirus infection screening: Difference between revisions
No edit summary |
m (Bot: Removing from Primary care) |
||
| (7 intermediate revisions by 2 users not shown) | |||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
All donors and transplant candidates should be tested for [[Cytomegalovirus infection|CMV]] [[serology]] prior to [[transplantation]] in order to allow for risk stratification and guide prevention strategies. | |||
==Screening== | ==Screening== | ||
All donors and transplant candidates should be tested for [[Cytomegalovirus infection|CMV]] serology prior to [[transplantation]] in order to allow for risk stratification and guide prevention strategies. | |||
==References== | |||
{{Reflist|2}} | |||
[[Category:Emergency medicine]] | |||
[[Category:Disease]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | |||
[[Category:Neurology]] | |||
[[Category:Neurosurgery]] | |||
[[Category:Gastroenterology]] | |||
[[Category:Ophthalmology]] | |||
Latest revision as of 21:13, 29 July 2020
|
Cytomegalovirus infection Microchapters |
|
Differentiating Cytomegalovirus infection from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Cytomegalovirus infection screening On the Web |
|
American Roentgen Ray Society Images of Cytomegalovirus infection screening |
|
Risk calculators and risk factors for Cytomegalovirus infection screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aravind Kuchkuntla, M.B.B.S[2]
Overview
All donors and transplant candidates should be tested for CMV serology prior to transplantation in order to allow for risk stratification and guide prevention strategies.
Screening
All donors and transplant candidates should be tested for CMV serology prior to transplantation in order to allow for risk stratification and guide prevention strategies.